Skip to main content

Psoriatic arthritis

    Hitting the home stretch, day 3 presentations were big! Here are a few of my favorites: Secukinumab Efficacy in Enthesitis-Related and Juvenile Psoriatic Arthritis. Abstract 1424 – Dr. Hermine…
    Should we start considering therapeutic drug monitoring when prescribing TNFi for treatment of our rheumatologic conditions? The NOR-DRUM trials (A and B) are the first randomized trials to assess…
    RT @RichardPAConway: Hospitalisation for heart failure ⬆️ in inflammatory diseases. RA>PsA>AS>PsO . HRs 1.1
    2 years 5 months ago
    Hospitalisation for heart failure ⬆️ in inflammatory diseases. RA>PsA>AS>PsO . HRs 1.1-1.6 compared to general population. Abstr#1925 #ACR21 @RheumNow https://t.co/kKlGQM5Tcg
    RT @Janetbirdope: Why is there more CHF in #RheumatoidArthritis ? Also dose response between highest inflammation RA the
    2 years 5 months ago
    Why is there more CHF in #RheumatoidArthritis ? Also dose response between highest inflammation RA the PsA then axSpA then PsO. ?Cytokine profile varying with disease and maybe CRP. Who knows. Abst#1925 #ACR21 @RheumNow https://t.co/JIH3qwkLpx
    RT @doctorRBC: Should we be measuring drug levels in pts taking infliximab?
    ⭐️Drug monitoring vs. standard dosing sh
    2 years 5 months ago
    Should we be measuring drug levels in pts taking infliximab? ⭐️Drug monitoring vs. standard dosing showed 73% sustained control vs. 55% (RA, PsA, SpA, UC, Crohn's, PsO) #ACR21 Abs#1946 #ACRBest @RheumNow https://t.co/sWMen50ljP https://t.co/F4Wpqis3id
    RT @_Castillo_Pedro: Prospective study of PsO screened @ derm clinics
    🔹PsO➕>3 mo back pain starting <45yo➕n
    2 years 5 months ago
    Prospective study of PsO screened @ derm clinics 🔹PsO➕>3 mo back pain starting <45yo➕no biologics➡️rheum ref, 100 pts seen➡️19 dx'ed as: 🔹14 axPsA, 68% met axSpA ASAS, 11/14 w/o pPsA 🔹5 pPsA w/o axial dz https://t.co/azoks5CHCP #ACR21 Abst#1796 @RheumNow
    RT @doctorRBC: Elevated CRP levels (&gt;3) in PsA associated with ⬆️risk of cardiovascular events
    ⭐️NSAID use si
    2 years 5 months ago
    Elevated CRP levels (>3) in PsA associated with ⬆️risk of cardiovascular events ⭐️NSAID use significantly REDUCED risk of CV events Abs#1920 #ACR21 @RheumNow https://t.co/gIz9f4SlWo https://t.co/V4uDeO3Iuz
    RT @swethaann23: Racial differences in PsA patients in large US real world database

    95% Whites (W) and 5% were AA
    NSA
    2 years 5 months ago
    Racial differences in PsA patients in large US real world database 95% Whites (W) and 5% were AA NSAIDs: 80% W and 78% AAs TNFI: 51% W and 41% of AAs DMARDs: 72% of W and 98% of AAs HTN/DM/Obesity/Gout 🔼 AA Cancer/osteoporosis /anxiety 🔼 whites Abst#1780 #ACR21 @Rheumnow https://t.co/7ee4bVU7ZA
    RT @swethaann23: PsO vs PsA patient and disease characteristics COPPAR registry:

    PsO pts 🔼mean BSA
    Both 🔼 % of
    2 years 5 months ago
    PsO vs PsA patient and disease characteristics COPPAR registry: PsO pts 🔼mean BSA Both 🔼 % of biologic therapy sPGA and PASI 🔼PsO 🔽QOL and physical health in PsA 🔼daily work impairment PsA Abst # 1779 #ACR21 @RheumNow